BAC Bank of America

Bank of America is the second-largest US bank by assets, offering consumer banking, wealth management, investment banking, and global markets services to individuals and institutions. Sector: Financials.

Bank of America (BAC) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Through the lens of capital efficiency, capital return data is limited for this snapshot. Supporting metrics show ROE at 10.21% and ROA at 0.90%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, capital efficiency metrics are insufficiently populated to form a complete assessment.

Assessed on a multiple basis, trailing P/E of 12.93, forward P/E of 11.37, PEG of 1.52. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. Growth-adjusted, the multiple is in an acceptable range — the company is neither pricing in perfection nor offering a meaningful valuation discount. Current ratio data is unavailable in the current snapshot. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

The margin profile breaks down as follows: gross margin sits at N/A, operating margin at 35.09%, and free cash flow margin at 11.45%. Gross margin data is unavailable in the current snapshot. Operating margins are exceptional, indicating management teams that scale revenues while keeping costs tightly controlled. The company's FCF margin is adequate — cash generation is present, but capital expenditure needs absorb a notable portion of earnings. This stack calls for monitoring: profitability is present, but conversion from revenue to operating income to free cash is not fully consistent.

The growth and outlook picture reads as follows: TTM revenue growth of 25.01% pointing to healthy demand conditions for the company represented in the company. In parallel, analysts project moderate appreciation over the next 12 months based on current consensus targets. The gap between trailing fundamentals and forward expectations matters most at inflection points — and the current environment is not without those. For long-term holders, the central question is whether today's execution quality is a leading indicator of what's already priced into analyst targets. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The data points reviewed collectively point toward a positive outcome if execution holds — the setup is favorable even accounting for the inherent uncertainty in forward estimates.

This summary is based on publicly available quantitative data and is not intended as investment advice. Carefully consider your personal financial circumstances before making any decisions.